1-3 of 3
Persis Jal Amrolia
Close
Sort by
Journal Articles

First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL

Waseem Qasim, MBBS PhD, Persis Jal Amrolia, Sujith Samarasinghe, MD PhD, Sara Ghorashian, MD PhD FRCPath, Hong Zhan, PhD, Sian Stafford, PhD, Katie Butler, PhD, Gul Ahsan, Kimberly Gilmour, Stuart Adams, PhD, Danielle Pinner, Robert Chiesa, Steve Chatters, PhD, Sue Swift, PhD, Nicholas Goulden, MD PhD, Karl Peggs, MBBChir, MRCP, FRCPath, Adrian J Thrasher, MD PhD, Paul Veys, Martin Pule, PhD
Journal: Blood
Blood (2015) 126 (23): 2046.
https://doi.org/10.1182/blood.V126.23.2046.2046
Published: 2015
Journal Articles

The Best of Both? Megadose Stem Cells with CD34 Selection and T-Cell Addback Enables Engraftment from Mismatched Unrelated Donors Using Reduced Toxicity Conditioning in Primary Immunodeficiency

Juliana Montibeller Silva, MD, Kanchan Rao, MNAMS (Paed), MRCP (Paed), Robert Chiesa, Stuart Adams, PhD, Margaret Brocklesby, Gulrukh Ahsan, Giovanna Lucchini, Paul Veys, Persis Jal Amrolia, Nicholas Goulden, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4303.
https://doi.org/10.1182/blood.V126.23.4303.4303
Published: 2015
Journal Articles

Allogeneic Stem Cell Transplantation for Refractory Acute Myeloid Leukemia in Pediatric Patients: The UK Experience

Patricia M O'Hare, Giovanna Lucchini, Michelle Cummins, Paul Veys, Mike Potter, Sarah Lawson, Ajay J. Vora, Robert Wynn, Andrew Peniket, Keiren Kirkland, Rachel Pearce, Julia Perry, Persis Jal Amrolia
Journal: Blood
Blood (2015) 126 (23): 4404.
https://doi.org/10.1182/blood.V126.23.4404.4404
Published: 2015